KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to $99.0 million.

  • Incyte's Cost of Revenue rose 1512.68% to $99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.4 million, marking a year-over-year increase of 1571.79%. This contributed to the annual value of $312.1 million for FY2024, which is 2238.44% up from last year.
  • According to the latest figures from Q3 2025, Incyte's Cost of Revenue is $99.0 million, which was up 1512.68% from $78.8 million recorded in Q2 2025.
  • Over the past 5 years, Incyte's Cost of Revenue peaked at $99.0 million during Q3 2025, and registered a low of $29.2 million during Q1 2021.
  • In the last 5 years, Incyte's Cost of Revenue had a median value of $60.1 million in 2023 and averaged $61.9 million.
  • In the last 5 years, Incyte's Cost of Revenue surged by 4583.85% in 2022 and then soared by 278.21% in 2025.
  • Quarter analysis of 5 years shows Incyte's Cost of Revenue stood at $43.9 million in 2021, then surged by 34.85% to $59.2 million in 2022, then increased by 17.9% to $69.8 million in 2023, then increased by 26.86% to $88.5 million in 2024, then increased by 11.88% to $99.0 million in 2025.
  • Its Cost of Revenue was $99.0 million in Q3 2025, compared to $78.8 million in Q2 2025 and $73.2 million in Q1 2025.